India
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
38.87%
|
March 31, 2024 | USD 32.02 | -0.02% |
|
India |
|
2 |
33.78%
|
March 31, 2024 | USD 7.16 | 0.59% |
|
India |
|
3 |
18.54%
|
March 31, 2024 | USD 8.48 | -0.45% |
|
India |
|
4 |
16.84%
|
March 31, 2024 | USD 20.94 | -0.93% |
|
India |
|
5 |
16.21%
|
March 31, 2024 | USD 8.93 | -4.20% |
|
India |
|
6 |
15.68%
|
March 31, 2024 | USD 1.17 | -2.09% |
|
India |
|
7 |
7.81%
|
March 31, 2024 | USD 11.39 | -5.33% |
|
India |
|
8 |
5.50%
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
9 |
3.11%
|
March 31, 2024 | USD 0.56 | -2.22% |
|
India |
|
10 |
-4.12%
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
|
11 |
-32.54%
|
March 31, 2024 | USD 0.13 | -2.33% |
|
India |
|
12 |
-544.71%
|
March 31, 2024 | USD 1.80 | -0.88% |
|
India |
|
13 |
-1,048.35%
|
March 31, 2024 | USD 1.50 | 0.58% |
|
India |
The Clinical Trials company in India with the highest Operating Income Margin is Dr. Lal PathLabs Limited (NSE: LALPATHLAB.NS) at 38.87%.
The Clinical Trials company in India with the lowest Operating Income Margin is Suven Life Sciences Limited (NSE: SUVEN.NS) at -1,048.35%.
The top 10 Clinical Trials companies in India by Operating Income Margin are Dr. Lal PathLabs Limited, Indegene Limited, Syngene International Limited, Metropolis Healthcare Limited, Thyrocare Technologies Limited, Ind-Swift Laboratories Limited, Jubilant Pharmova Limited, Glenmark Pharmaceuticals Limited, Vineet Laboratories Limited and Vimta Labs Limited.
The bottom 10 Clinical Trials companies in India by Operating Income Margin are Suven Life Sciences Limited, Sun Pharma Advanced Research Company Limited, TAKE Solutions Limited, Vimta Labs Limited, Vineet Laboratories Limited, Glenmark Pharmaceuticals Limited, Jubilant Pharmova Limited, Ind-Swift Laboratories Limited, Thyrocare Technologies Limited and Metropolis Healthcare Limited.